Search results for "oligonucleotide"
Article
Future Downstream Process Development Solutions for Advanced Therapies
Related Content
Q&As with Industry Leaders
mRNA manufacturing strategies
Manufacturing of viral vectors
Purification of plasmids
Oligonucleotide therapeutics
Article
Gene Therapies Push Viral Vector Production
“Apart from plasmids there are liposomes, lipoplexes, polyplexes, and oligonucleotides [that can be used] as non-viral modes of gene delivery.”
Vicaire also notes that using non-viral vehicles …
Article
Biopharma Manufacturers Respond to Ebola Crisis
And Sarepta Therapeutics (Cambridge, MA) is looking to produce clinical supplies of its oligonucleotide (AVI 7537) for initial studies.
A promising treatment is favipiravir (T-705), an oral tablet…
Article
Q&As with Industry Leaders
Putrich, BioPharm International
John Scibetta, Advanced Chromatography Specialist, Cytiva
Q&A: Oligonucleotide Synthesis in Process Development and Scale-Up
Megan Manzano, BioPh…
Article
Quality by Design—Bridging the Gap between Concept and Implementation
The drive to embed quality-by-design (QbD) principles into the pharmaceutical regulatory framework of the European Union has reached a key point 10 years after the European Medicines Agency (EMA) firs…